NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Technicians always believe after a big advance they'll be a 30% to 50% retrenchment of the advance. That said, our advance could continue moving up until approval. The peak established there could be where we retrench from. With $.20 considered the base, if we achieve anything above $3 it hardly matters whether you look at $.20 as the base, or zero as the percentage doesn't change that much. If we reach $3, retrenching to $2 or near $1.50 would be expected by the technicians. That would establish a new base for the next advance.

The question for investors is whether getting out at the high, and back in after retrenchment makes sense when considering tax consequences. It becomes much clearer if the peak's at $10 and retrenchment is anticipated to near $5.

To me, $5 represents about an $8 billion market cap, I believe that more than UK approval alone is needed to trade stabile at that price. I believe more will be coming, I'm uncertain how quickly.

Regardless of where we are post approval, I believe by the end of the year we'll see $5 to $10, or more. There will be a great deal of news between approval and then.

Gary